Dr. Elliot Bland is a seasoned life science executive with extensive experience in driving growth and value creation for early-stage biotechnology companies. As VP Operations and Business Development Director at iosBio Ltd, he has been instrumental in securing significant funding, leading operations for vaccine development, and executing strategic out-licensing deals. Prior to this, Dr. Bland held leadership roles in technology transfer at Queen Mary Innovations and business development at SLA Pharma AG and NHS Innovations London, consistently delivering strong results in licensing, fundraising, and commercialisation of innovative technologies. His expertise spans from preclinical development and regulatory pathways to commercial agreements and strategic partnerships.